Third-Generation Bruton tyrosine kinase Inhibitors for the Treatment of Monoclonal Gammopathy of Thrombotic Significance (MGTS).
Saved in:
| Title: | Third-Generation Bruton tyrosine kinase Inhibitors for the Treatment of Monoclonal Gammopathy of Thrombotic Significance (MGTS). |
|---|---|
| Authors: | Man L; Department of Medicine, University of Virginia, Charlottesville, Virginia, USA., Kanack AJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Mauch EE; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Splinter NP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Padmanabhan A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. |
| Source: | American journal of hematology [Am J Hematol] 2025 Dec; Vol. 100 (12), pp. 2377-2381. Date of Electronic Publication: 2025 Sep 13. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1096-8652 |
|---|---|
| DOI: | 10.1002/ajh.70078 |
